- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 15, 2025 | 58.84M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 46.62M sh |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 19.99M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | $8.15K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$44.77K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $0 |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$11.2M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$11.92M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | −$11.15M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | −$10.95M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $10.61M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $10.75M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $10.63M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $11.39M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $8.26K |
| Current Assets | Q1 2025 · Dec 31, 2024 | $50.12K |
| Total Assets | Q1 2025 · Mar 31, 2025 | $8.26K |
| Total Assets | Q1 2025 · Dec 31, 2024 | $50.12K |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.00 |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$0.00 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $68.93K |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $97.46K |
| Net Income | Q1 2025 · Mar 31, 2025 | −$215.8K |
| Net Income | Q1 2025 · Dec 31, 2024 | −$1.06M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$265.42K |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$68.93K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$97.46K |